NKX2-1 and nasopharyngeal carcinoma: Gene-based burden testing results showed an association between NKX2-1 and NPC risk, as two of 119 cases (1.7%) but none of the 1337 controls had variants in NKX2-1 (FDR-adjusted p = 0.0144) (Table 3).